Results 81 to 90 of about 135,768 (300)

Population pharmacokinetics of levofloxacin in breastmilk in patients with rifampicin‐resistant tuberculosis

British Journal of Clinical Pharmacology, EarlyView.
Levofloxacin is a widely used antibiotic included in rifampicin‐resistant tuberculosis (RR‐TB) treatment. Data describing levofloxacin concentrations in breastmilk and infant exposure are limited. We analysed data from two South African studies of breastfeeding women receiving levofloxacin (750–1000 mg daily) for RR‐TB.
Sharon Sawe, Lufina Tsirizani, Buyisile Mkhize, Lubbe Wiesner, Gary Maartens, Francesca Conradie, Richard Court, Marian Loveday, Catriona Waitt, Paolo Denti   +9 more
wiley   +1 more source

Incidence of Aeromonas bacteremia in Southern Taiwan: Vibrio and Salmonella bacteremia as comparators [PDF]

, 2012
[[abstract]]The aim of the investigation was to describe the incidence of Aeromonas bacteremia in a city with a population of about 1.87 million inhabitants, located in southern Taiwan, between 2008 and 2010.
Wu, CJ;Chen, PL;Tang, HJ;Chen, HM;Tseng, FC;Shih, HI;Hung, YP;Chung, CH;Ko, WC
core   +2 more sources

Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence

Journal of Microbiology, Immunology and Infection, 2018
Background: The aim of this study was to compare the risk factors and clinical outcomes of bacteremia in allogeneic and autologous hematopoietic stem cell transplant (allo-HSCT and auto-HSCT) recipients with levofloxacin prophylaxis during the early ...
Ching-Hsun Wang, Feng-Yee Chang, Tsu-Yi Chao, Woei-Yau Kao, Ching-Liang Ho, Yeu-Chin Chen, Ming-Shen Dai, Ping-Ying Chang, Yi-Ying Wu, Jung-Chung Lin   +9 more
doaj   +1 more source

Stenotrophomonas maltophilia Bacteremia: From Diagnosis to Treatment

, 2022
Objective: There are many difficulties in diagnosing and treating Stenotrophomonas maltophilia bacteremia. In this study, we aimed to evaluate "true" and "false-positive bacteremia" and assess mortality risk factors and the impact of different treatment ...
Habibi, Hamid, Aysert Yıldız, Pınar, Özger, Hasan Selçuk, Dizbay, Murat, Yıldız, Yeşim, Eser, Sedanur, Özgen Top, Özge   +6 more
core   +1 more source

Ceftriaxone‐induced liver injury: Incidence, phenotypic characterization and predictive factors

British Journal of Clinical Pharmacology, EarlyView.
Introduction Ceftriaxone is a widely used third‐generation cephalosporin in hospitalized patients. Although generally considered safe, it has been associated with hepatobiliary complications and emerging reports of drug‐induced liver injury (DILI). However, data on its true incidence, phenotypic patterns, and predictors remain limited. This study aimed
Mohamed Hatem, Mohannad N. AbuHaweeleh, Humam Emad Rajha, Mhd Osama Rahhal, Ahmad Hamdan, Lina Naseralallah   +5 more
wiley   +1 more source

Comparison of clinical features between bacteremia (+) and bacteremia (-) subgroups.

, 2019
Comparison of clinical features between bacteremia (+) and bacteremia (-) subgroups.
Jaewoong Lee (7870055), Eun-Jee Oh (727761), Dong Gun Lee (6190070), Yoon-Joo Kim (8108087), Mina Yang (6332195), Seung Jun Choi (8108084), Yeon-Joon Park (694465)   +6 more
core   +1 more source

Cefepime exposure in prolonged or intermittent infusion in critically ill children

British Journal of Clinical Pharmacology, EarlyView.
Aims Cefepime is commonly used in critically ill children for whom there is a high between‐subject variability. To reach the therapeutic pharmacokinetic (PK) target in critically ill patients, prolonged infusion of beta‐lactams seems to be the most efficient.
Marc Hobeika, Deborah Hirt, Emmanuelle Bille, Sihem Benaboud, Julie Toubiana, Pierre‐Louis Léger, Jérôme Rambaud, Agathe Béranger, Delphine Callot, Sylvain Renolleau, Jean‐Marc Treluyer, Mehdi Oualha, Noémie de Cacqueray   +12 more
wiley   +1 more source

Metabolic response to Klebsiella pneumoniae infection in an experimental rat model.

PLoS ONE, 2012
Bacteremia, the presence of viable bacteria in the blood stream, is often associated with several clinical conditions. Bacteremia can lead to multiple organ failure if managed incorrectly, which makes providing suitable nutritional support vital for ...
Fangcong Dong, Bin Wang, Lulu Zhang, Huiru Tang, Jieshou Li, Yulan Wang   +5 more
doaj   +1 more source

bacteremia

, 2019
The inflammasome is a multiprotein complex that mediates caspase-1 activation with subsequent maturation of the pro-inflammatory cytokines IL-1β and IL-18.
Rasmussen, Gunlög,, Idosa, BA, Monecke, S, Soderquist, B, Kristoffer Strålin, Backman, A, Stralin, K, Bo Söderquist, Monecke, S.,, Bäckman, Anders,, Asfaw Idosa, Berhane,, Särndahl, Eva,, Sarndahl, E, Söderquist, Bo,, Gunlög Rasmussen, Stefan Monecke, Berhane Asfaw Idosa, Anders Bäckman, Rasmussen, G, Eva Särndahl, Strålin, Kristoffer,   +20 more
core   +1 more source

Clinical and Microbiological Determinants of Outcome in Staphylococcus aureus Bacteraemia. [PDF]

, 2010
Staphylococcus aureus bacteraemia (SAB) is commonly complicated by metastatic infection or relapse after treatment. Objectives. The study aim was to determine the role of bacterial, host, and management factors in development of complicated SAB. Methods.
Karen Walker-Bone, Lindsay, J., Llewelyn, M, Heath, I., Curtis, S., Jodi Lindsay (378699), Lindsay, J, Gillian Baker (16048691), Sally Curtis (11260241), Cubbon, M., Paul, J., John Paul (744142), Llewelyn, M., James Price (6728021), Enright, M.C., Martin Llewelyn (4461757), James Price, Mark C Enright (16048700), Walker-Bone, K., Enright, MC, Curtis, S, Mark C Enright, Martin Llewelyn, Ian Heath, Marc Cubbon, Walker-Bone, K, Price, J., Gillian Baker, Jodi Lindsay, Karen Walker-Bone (2634085), Mark C. Enright, John Paul, Baker, G., Paul, J, Cubbon, M, Sally Curtis, Ian Heath (16048694), Marc Cubbon (16048697), Enright, Mark, Baker, G, Price, J, Heath, I   +41 more
core   +1 more source